The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
High mobility group box domain
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 1: transcription factor 7 isoform X2

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 72 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
17 A0A0R4II86 (/TAS) A0A2R8Q6H8 (/TAS) A0A2R8QK61 (/TAS) A5A8K1 (/TAS) B3DIS1 (/TAS) F1QZD5 (/TAS) F1RAG0 (/TAS) F6NVS9 (/TAS) F8W2J8 (/TAS) F8W4S5 (/TAS)
(7 more)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
17 P27782 (/IPI) P27782 (/IPI) P36402 (/IPI) P70062 (/IPI) P70062 (/IPI) P91943 (/IPI) Q90ZB6 (/IPI) Q90ZB6 (/IPI) Q924A0 (/IPI) Q9NQB0 (/IPI)
(7 more)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
10 P27782 (/IDA) P27782 (/IDA) P70062 (/IDA) P70062 (/IDA) Q924A0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
9 P27782 (/IDA) P27782 (/IDA) Q00417 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA) Q9Z1J1 (/IDA)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
9 P27782 (/IDA) P27782 (/IDA) P36402 (/IDA) Q924A0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
8 D3YWT3 (/IDA) P27782 (/IDA) P27782 (/IDA) Q00417 (/IDA) Q924A0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
8 O93345 (/ISS) Q56R97 (/ISS) Q56R97 (/ISS) Q5R2J3 (/ISS) Q9QXN1 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS) Q9W7C0 (/ISS)
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
8 O93345 (/ISS) Q56R97 (/ISS) Q56R97 (/ISS) Q5R2J3 (/ISS) Q9QXN1 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS) Q9W7C0 (/ISS)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
7 P36402 (/ISA) Q9HCS4 (/ISA) Q9NQB0 (/ISA) Q9NQB0 (/ISA) Q9NQB0 (/ISA) Q9UJU2 (/ISA) Q9UJU2 (/ISA)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
7 P36402 (/ISM) Q9HCS4 (/ISM) Q9NQB0 (/ISM) Q9NQB0 (/ISM) Q9NQB0 (/ISM) Q9UJU2 (/ISM) Q9UJU2 (/ISM)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
7 P36402 (/NAS) Q9HCS4 (/NAS) Q9NQB0 (/NAS) Q9NQB0 (/NAS) Q9NQB0 (/NAS) Q9UJU2 (/NAS) Q9UJU2 (/NAS)
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
7 P36402 (/IDA) Q924A0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
7 Q924A0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9UJU2 (/IPI) Q9UJU2 (/IPI) Q9Z1J1 (/IPI)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
7 P27782 (/IPI) P27782 (/IPI) P70062 (/IPI) P70062 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
5 P27782 (/IDA) P27782 (/IDA) Q00417 (/IDA) Q9YHE8 (/IDA) Q9Z1J1 (/IDA)
Gamma-catenin binding GO:0045295
Interacting selectively and non-covalently with the gamma subunit of the catenin complex.
5 Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9UJU2 (/IPI) Q9UJU2 (/IPI)
Armadillo repeat domain binding GO:0070016
Interacting selectively and non-covalently with the armadillo repeat domain of a protein, an approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity protein armadillo. Arm-repeat proteins are involved in various processes, including intracellular signalling and cytoskeletal regulation.
5 Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9UJU2 (/IPI) Q9UJU2 (/IPI)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
4 O93345 (/ISS) Q5R2J3 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
4 D3YWT3 (/IDA) P27782 (/IDA) P27782 (/IDA) P91943 (/IDA)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
4 P27782 (/IDA) P27782 (/IDA) Q924A0 (/IDA) Q9Z1J1 (/IDA)
RNA polymerase II repressing transcription factor binding GO:0001103
Interacting selectively and non-covalently with an RNA polymerase II transcription repressing factor, a protein involved in negative regulation of transcription.
3 Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
3 O93345 (/ISS) Q5R2J3 (/ISS) Q6GL68 (/ISS)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
3 Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI)
Nuclear hormone receptor binding GO:0035257
Interacting selectively and non-covalently with a nuclear hormone receptor, a ligand-dependent receptor found in the nucleus of the cell.
3 Q9NQB0 (/IPI) Q9NQB0 (/IPI) Q9NQB0 (/IPI)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
3 A0A0R4II86 (/IPI) F6NVS9 (/IPI) Q9W7C0 (/IPI)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Gamma-catenin binding GO:0045295
Interacting selectively and non-covalently with the gamma subunit of the catenin complex.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Armadillo repeat domain binding GO:0070016
Interacting selectively and non-covalently with the armadillo repeat domain of a protein, an approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity protein armadillo. Arm-repeat proteins are involved in various processes, including intracellular signalling and cytoskeletal regulation.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977
Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.
2 P27782 (/ISO) P27782 (/ISO)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P91943 (/IDA) Q8IMA8 (/IDA)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P27782 (/IGI) P27782 (/IGI)
DNA-binding transcription factor activity, RNA polymerase II-specific GO:0000981
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 O93345 (/ISS) Q5R2J3 (/ISS)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 P27782 (/ISO) P27782 (/ISO)
DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to activate or increase transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
2 O93345 (/ISS) Q5R2J3 (/ISS)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Beta-catenin binding GO:0008013
Interacting selectively and non-covalently with the beta subunit of the catenin complex.
2 Q9UJU2 (/TAS) Q9UJU2 (/TAS)
DNA binding, bending GO:0008301
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
2 P27782 (/IDA) P27782 (/IDA)
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
2 P91943 (/IPI) Q8IMA8 (/IPI)
Estrogen receptor activity GO:0030284
Combining with estrogen and transmitting the signal within the cell to trigger a change in cell activity or function.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Estrogen receptor activity GO:0030284
Combining with estrogen and transmitting the signal within the cell to trigger a change in cell activity or function.
2 P27782 (/ISO) P27782 (/ISO)
Estrogen receptor binding GO:0030331
Interacting selectively and non-covalently with an estrogen receptor.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Estrogen receptor binding GO:0030331
Interacting selectively and non-covalently with an estrogen receptor.
2 P27782 (/ISO) P27782 (/ISO)
Enhancer binding GO:0035326
Interacting selectively and non-covalently with an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Enhancer binding GO:0035326
Interacting selectively and non-covalently with an enhancer, a transcription regulatory region that is somewhat distal from the core promoter and which enhances transcription from that promoter.
2 P27782 (/ISO) P27782 (/ISO)
Histone binding GO:0042393
Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of eukaroytic chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity.
2 Q9UJU2 (/IPI) Q9UJU2 (/IPI)
Histone binding GO:0042393
Interacting selectively and non-covalently with a histone, any of a group of water-soluble proteins found in association with the DNA of eukaroytic chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity.
2 P27782 (/ISO) P27782 (/ISO)
Histone deacetylase binding GO:0042826
Interacting selectively and non-covalently with the enzyme histone deacetylase.
2 Q9UJU2 (/IPI) Q9UJU2 (/IPI)
Histone deacetylase binding GO:0042826
Interacting selectively and non-covalently with the enzyme histone deacetylase.
2 P27782 (/ISO) P27782 (/ISO)
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
2 P27782 (/ISO) P27782 (/ISO)
Sequence-specific DNA binding GO:0043565
Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Transcription regulatory region DNA binding GO:0044212
Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Repressing transcription factor binding GO:0070491
Interacting selectively and non-covalently with a transcription repressor, any protein whose activity is required to prevent or downregulate transcription.
2 P91943 (/IPI) Q8IMA8 (/IPI)
C2H2 zinc finger domain binding GO:0070742
Interacting selectively and non-covalently with a C2H2-type zinc finger domain of a protein. The C2H2 zinc finger is the classical zinc finger domain, in which two conserved cysteines and histidines co-ordinate a zinc ion.
2 Q9UJU2 (/IPI) Q9UJU2 (/IPI)
C2H2 zinc finger domain binding GO:0070742
Interacting selectively and non-covalently with a C2H2-type zinc finger domain of a protein. The C2H2 zinc finger is the classical zinc finger domain, in which two conserved cysteines and histidines co-ordinate a zinc ion.
2 P27782 (/ISO) P27782 (/ISO)
RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978
Interacting selectively and non-covalently with a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in the proximal promoter of a gene transcribed by RNA polymerase II. The proximal promoter is in cis with and relatively close to the core promoter.
1 Q924A0 (/ISO)
RNA polymerase II distal enhancer sequence-specific DNA binding GO:0000980
Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter.
1 Q8IMA8 (/IDA)
RNA polymerase II repressing transcription factor binding GO:0001103
Interacting selectively and non-covalently with an RNA polymerase II transcription repressing factor, a protein involved in negative regulation of transcription.
1 Q924A0 (/ISO)
DNA-binding transcription repressor activity, RNA polymerase II-specific GO:0001227
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a RNA polymerase II-transcribed gene to repress or decrease transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units.
1 Q00417 (/IMP)
DNA binding GO:0003677
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
1 Q9HCS4 (/NAS)
Chromatin binding GO:0003682
Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
1 Q924A0 (/IGI)
DNA-binding transcription factor activity GO:0003700
A protein or a member of a complex that interacts selectively and non-covalently with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
1 Q9HCS4 (/NAS)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
1 Q924A0 (/ISO)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
1 Q924A0 (/ISO)
Nuclear hormone receptor binding GO:0035257
Interacting selectively and non-covalently with a nuclear hormone receptor, a ligand-dependent receptor found in the nucleus of the cell.
1 Q924A0 (/ISO)

There are 307 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
23 A0A0R4II86 (/IMP) A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP)
(13 more)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
17 A0A0R4II86 (/IGI) A0A2R8Q6H8 (/IGI) A0A2R8QK61 (/IGI) A5A8K1 (/IGI) B3DIS1 (/IGI) F1QZD5 (/IGI) F1RAG0 (/IGI) F6NVS9 (/IGI) F8W2J8 (/IGI) F8W4S5 (/IGI)
(7 more)
Response to lithium ion GO:0010226
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
16 A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP) Q6DEL9 (/IMP)
(6 more)
Habenula development GO:0021986
The progression of the habenula over time from its initial formation until its mature state. The habenula is the group of nuclei that makes up the stalk of the pineal gland.
16 A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP) Q6DEL9 (/IMP)
(6 more)
Exocrine pancreas development GO:0031017
The process whose specific outcome is the progression of the exocrine pancreas over time, from its formation to the mature structure. The exocrine pancreas produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells.
16 A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP) Q6DEL9 (/IMP)
(6 more)
Determination of left/right asymmetry in diencephalon GO:0035462
The establishment of the diencephalon with respect to the left and right halves.
16 A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP) Q6DEL9 (/IMP)
(6 more)
Digestive system development GO:0055123
The process whose specific outcome is the progression of the digestive system over time, from its formation to the mature structure. The digestive system is the entire structure in which digestion takes place. Digestion is all of the physical, chemical, and biochemical processes carried out by multicellular organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
16 A0A2R8Q786 (/IGI) A0A2R8QTB4 (/IGI) A0A2R8RU78 (/IGI) B3DKP7 (/IGI) E9QC17 (/IGI) E9QFQ3 (/IGI) F1Q7T6 (/IGI) F1QC44 (/IGI) F1RC81 (/IGI) Q6DEL9 (/IGI)
(6 more)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
16 A0A2R8Q786 (/TAS) A0A2R8QTB4 (/TAS) A0A2R8RU78 (/TAS) B3DKP7 (/TAS) E9QC17 (/TAS) E9QFQ3 (/TAS) F1Q7T6 (/TAS) F1QC44 (/TAS) F1RC81 (/TAS) Q6DEL9 (/TAS)
(6 more)
Intestinal epithelial structure maintenance GO:0060729
A tissue homeostatic process required for the maintenance of the structure of the intestinal epithelium.
16 A0A2R8Q786 (/IMP) A0A2R8QTB4 (/IMP) A0A2R8RU78 (/IMP) B3DKP7 (/IMP) E9QC17 (/IMP) E9QFQ3 (/IMP) F1Q7T6 (/IMP) F1QC44 (/IMP) F1RC81 (/IMP) Q6DEL9 (/IMP)
(6 more)
Fin development GO:0033333
The process whose specific outcome is the progression of a fin over time, from its formation to the mature structure.
15 A0A0R4II86 (/IMP) A0A2R8Q6H8 (/IMP) A0A2R8QK61 (/IMP) A5A8K1 (/IMP) B3DIS1 (/IMP) F1QZD5 (/IMP) F1RAG0 (/IMP) F6NVS9 (/IMP) F8W2J8 (/IMP) F8W4S5 (/IMP)
(5 more)
Pectoral fin development GO:0033339
The process whose specific outcome is the progression of the pectoral fin over time, from its formation to the mature structure.
15 A0A0R4II86 (/IMP) A0A2R8Q6H8 (/IMP) A0A2R8QK61 (/IMP) A5A8K1 (/IMP) B3DIS1 (/IMP) F1QZD5 (/IMP) F1RAG0 (/IMP) F6NVS9 (/IMP) F8W2J8 (/IMP) F8W4S5 (/IMP)
(5 more)
Spinal cord dorsal/ventral patterning GO:0021513
The process that regulates the coordinated growth and differentiation that establishes the non-random dorsal-ventral spatial arrangement of the spinal cord.
12 A0A2R8Q6H8 (/IMP) A0A2R8QK61 (/IMP) A5A8K1 (/IMP) B3DIS1 (/IMP) F1QZD5 (/IMP) F1RAG0 (/IMP) F8W2J8 (/IMP) F8W4S5 (/IMP) F8W5T7 (/IMP) Q5PU93 (/IMP)
(2 more)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
10 P27782 (/IDA) P27782 (/IDA) Q8IMA8 (/IDA) Q924A0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA) Q9Z1J1 (/IDA)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
8 P27782 (/IDA) P27782 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA) Q9Z1J1 (/IDA)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
8 O93345 (/IMP) P27782 (/IMP) P27782 (/IMP) P91943 (/IMP) Q8IMA8 (/IMP) Q924A0 (/IMP) Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
8 O93345 (/IDA) P27782 (/IDA) P27782 (/IDA) Q00417 (/IDA) Q8IMA8 (/IDA) Q924A0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
7 P27782 (/IDA) P27782 (/IDA) P70062 (/IDA) P70062 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
7 P91943 (/IMP) Q8IMA8 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Beta-catenin-TCF complex assembly GO:1904837
The aggregation, arrangement and bonding together of a set of components to form a beta-catenin-TCF complex.
7 P36402 (/TAS) Q9HCS4 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9UJU2 (/TAS) Q9UJU2 (/TAS)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
6 D4A8X6 (/IMP) P27782 (/IMP) P27782 (/IMP) Q924A0 (/IMP) Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
6 A0A0R4II86 (/IGI) F6NVS9 (/IGI) P27782 (/IGI) P27782 (/IGI) Q924A0 (/IGI) Q9W7C0 (/IGI)
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
5 A0A0R4II86 (/IMP) F6NVS9 (/IMP) P27782 (/IMP) P27782 (/IMP) Q9W7C0 (/IMP)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
5 P27782 (/IDA) P27782 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Wnt signaling pathway, calcium modulating pathway GO:0007223
The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors leads to an increase in intracellular calcium and activation of protein kinase C (PKC).
5 Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9UJU2 (/TAS) Q9UJU2 (/TAS)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
5 A0A0R4II86 (/IMP) F6NVS9 (/IMP) P91943 (/IMP) Q8IMA8 (/IMP) Q9W7C0 (/IMP)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
4 O93345 (/ISS) Q5R2J3 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
4 P91943 (/IMP) Q800Q5 (/IMP) Q8IMA8 (/IMP) Q9YHE8 (/IMP)
Positive regulation of insulin secretion GO:0032024
Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
4 Q924A0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
T-helper 1 cell differentiation GO:0045063
The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 1 (Th1) cell. A Th1 cell is a CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive and produces interferon-gamma.
4 O93345 (/ISS) Q5R2J3 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
4 P27782 (/IDA) P27782 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
4 O93345 (/ISS) Q5R2J3 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS)
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
4 Q924A0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
3 D4A8X6 (/IMP) Q00417 (/IMP) Q924A0 (/IMP)
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
3 Q9NQB0 (/ISS) Q9NQB0 (/ISS) Q9NQB0 (/ISS)
Embryonic pattern specification GO:0009880
The process that results in the patterns of cell differentiation that will arise in an embryo.
3 P91943 (/IMP) Q800Q5 (/IMP) Q8IMA8 (/IMP)
Positive regulation of heparan sulfate proteoglycan biosynthetic process GO:0010909
Any process that increases the rate, frequency or extent of heparan sulfate proteoglycan biosynthesis. Heparan sulfate proteoglycan biosynthetic processes are the chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Hypothalamus development GO:0021854
The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Forebrain neuron differentiation GO:0021879
The process in which a relatively unspecialized cell acquires specialized features of a neuron that will reside in the forebrain.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Hypothalamus cell differentiation GO:0021979
The differentiation of cells that will contribute to the structure and function of the hypothalamus.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Neurogenesis GO:0022008
Generation of cells within the nervous system.
3 A0A0R4II86 (/IGI) F6NVS9 (/IGI) Q9W7C0 (/IGI)
Pancreas development GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
3 Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS)
Fin regeneration GO:0031101
The regrowth of fin tissue following its loss or destruction.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Regulation of hormone metabolic process GO:0032350
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
T cell receptor V(D)J recombination GO:0033153
The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
3 P27782 (/IGI) P27782 (/IGI) Q00417 (/IGI)
Fin morphogenesis GO:0033334
The process in which the anatomical structures of a fin are generated and organized.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Caudal fin development GO:0033336
The process whose specific outcome is the progression of the caudal fin over time, from its formation to the mature structure.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
3 P27782 (/IGI) P27782 (/IGI) Q924A0 (/IGI)
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Maintenance of DNA repeat elements GO:0043570
Any process involved in sustaining the fidelity and copy number of DNA repeat elements.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition GO:0044334
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of epithelial cell to mesenchymal cell transition.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Fat cell differentiation GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
3 P27782 (/IGI) P27782 (/IGI) Q924A0 (/IGI)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Alpha-beta T cell differentiation GO:0046632
The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex.
3 P27782 (/IGI) P27782 (/IGI) Q00417 (/IGI)
Positive regulation of protein export from nucleus GO:0046827
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Myoblast fate commitment GO:0048625
The process in which the developmental fate of a cell becomes restricted such that it will develop into a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Muscle fiber development GO:0048747
The process whose specific outcome is the progression of the muscle fiber over time, from its formation to the mature structure. In skeletal muscle, fibers are formed by the maturation of myotubes. They can be classed as slow, intermediate/fast or fast.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Posterior lateral line development GO:0048916
The process whose specific outcome is the progression of the posterior lateral line over time, from its formation to the mature structure. The posterior lateral line consists of small sensory patches (neuromasts) located superficially on the skin or just under the skin in fluid-filled canals on the body and trunk of all fishes and most amphibians. The posterior lateral line develops from cranial ectodermal placodes situated behind the ear.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Posterior lateral line neuromast development GO:0048919
The process whose specific outcome is the progression of the posterior lateral line neuromast over time, from its formation to the mature structure. The neuromast is the sensory receptor of the anterior lateral line system and is composed of a population of sensory hair cells, and nonsensory supporting cells and mantle cells. Neuromast are located superficially on the epithelium or in lateral line canals.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Posterior lateral line neuromast deposition GO:0048922
The process in which a migrating neuromast primordium deposits clusters of undifferentiated cells (proneuromasts) along its migratory path in the developing posterior lateral line.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Positive regulation of neurogenesis GO:0050769
Any process that activates or increases the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
3 Q9NQB0 (/IC) Q9NQB0 (/IC) Q9NQB0 (/IC)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
3 P27782 (/IGI) P27782 (/IGI) Q924A0 (/IGI)
Regulation of cell proliferation involved in tissue homeostasis GO:0060784
Any process that modulates the frequency, rate or extent of cell proliferation resulting in the maintenance of a steady-state number of cells within a tissue.
3 A0A0R4II86 (/IMP) F6NVS9 (/IMP) Q9W7C0 (/IMP)
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
3 O93345 (/ISS) Q9UJU2 (/ISS) Q9UJU2 (/ISS)
Cellular response to interleukin-4 GO:0071353
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
3 P36402 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
3 Q9NQB0 (/IMP) Q9NQB0 (/IMP) Q9NQB0 (/IMP)
Regulation of retinoic acid biosynthetic process GO:1900052
Any process that modulates the frequency, rate or extent of retinoic acid biosynthetic process.
3 A0A0R4II86 (/IGI) F6NVS9 (/IGI) Q9W7C0 (/IGI)
Negative regulation of type B pancreatic cell apoptotic process GO:2000675
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
3 Q9NQB0 (/ISS) Q9NQB0 (/ISS) Q9NQB0 (/ISS)
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
3 Q9NQB0 (/ISS) Q9NQB0 (/ISS) Q9NQB0 (/ISS)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
2 P27782 (/IMP) P27782 (/IMP)
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Osteoblast differentiation GO:0001649
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
2 Q9UJU2 (/IEP) Q9UJU2 (/IEP)
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
2 P27782 (/IGI) P27782 (/IGI)
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
2 P27782 (/IMP) P27782 (/IMP)
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
2 P27782 (/IMP) P27782 (/IMP)
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing vessels into avascular tissues, this process includes the specialization of endothelial cells into leading tip and stalk cells, proliferation and migration of the endothelial cells and cell adhesion resulting in angiogenic sprout fusion or lumen formation.
2 P27782 (/IMP) P27782 (/IMP)
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing vessels into avascular tissues, this process includes the specialization of endothelial cells into leading tip and stalk cells, proliferation and migration of the endothelial cells and cell adhesion resulting in angiogenic sprout fusion or lumen formation.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
2 Q00417 (/IDA) Q924A0 (/IDA)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
2 P91943 (/IMP) Q8IMA8 (/IMP)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Transcription by RNA polymerase II GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Transcription by RNA polymerase II GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
2 P27782 (/ISO) P27782 (/ISO)
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
2 P91943 (/IMP) Q8IMA8 (/IMP)
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
2 P91943 (/IMP) Q8IMA8 (/IMP)
Mesodermal cell fate determination GO:0007500
The cell fate determination process in which a cell becomes capable of differentiating autonomously into a mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
2 P91943 (/TAS) Q8IMA8 (/TAS)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2 Q800Q5 (/IGI) Q9YHE8 (/IGI)
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2 P91943 (/TAS) Q8IMA8 (/TAS)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
2 Q800Q5 (/IGI) Q9YHE8 (/IGI)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
2 P27782 (/ISO) P27782 (/ISO)
Cell proliferation in dorsal spinal cord GO:0010456
The multiplication or reproduction of cells, resulting in the expansion of the dorsal spinal cord cell population.
2 Q800Q5 (/IGI) Q9YHE8 (/IGI)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
2 P27782 (/ISO) P27782 (/ISO)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
2 P27782 (/ISO) P27782 (/ISO)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Dentate gyrus development GO:0021542
The process whose specific outcome is the progression of the dentate gyrus over time, from its formation to the mature structure. The dentate gyrus is one of two interlocking gyri of the hippocampus. It contains granule cells, which project to the pyramidal cells and interneurons of the CA3 region of the ammon gyrus.
2 P27782 (/IMP) P27782 (/IMP)
Dentate gyrus development GO:0021542
The process whose specific outcome is the progression of the dentate gyrus over time, from its formation to the mature structure. The dentate gyrus is one of two interlocking gyri of the hippocampus. It contains granule cells, which project to the pyramidal cells and interneurons of the CA3 region of the ammon gyrus.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
2 P27782 (/IMP) P27782 (/IMP)
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Forebrain radial glial cell differentiation GO:0021861
The process in which neuroepithelial cells of the neural tube give rise to radial glial cells, specialized bipotential progenitors cells of the forebrain. Differentiation includes the processes involved in commitment of a cell to a specific fate.
2 P27782 (/IGI) P27782 (/IGI)
Forebrain radial glial cell differentiation GO:0021861
The process in which neuroepithelial cells of the neural tube give rise to radial glial cells, specialized bipotential progenitors cells of the forebrain. Differentiation includes the processes involved in commitment of a cell to a specific fate.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Forebrain neuroblast division GO:0021873
The division of a neuroblast located in the forebrain. Neuroblast division gives rise to at least another neuroblast.
2 P27782 (/IGI) P27782 (/IGI)
Forebrain neuroblast division GO:0021873
The division of a neuroblast located in the forebrain. Neuroblast division gives rise to at least another neuroblast.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Rostrocaudal neural tube patterning GO:0021903
The process in which the neural tube is divided into specific regions along the rostrocaudal axis.
2 Q800Q5 (/IMP) Q9YHE8 (/IMP)
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
2 Q00417 (/IGI) Q924A0 (/IGI)
Formation of radial glial scaffolds GO:0021943
The formation of scaffolds from a radial glial cell. The scaffolds are used as a substrate for the radial migration of cells.
2 P27782 (/IGI) P27782 (/IGI)
Formation of radial glial scaffolds GO:0021943
The formation of scaffolds from a radial glial cell. The scaffolds are used as a substrate for the radial migration of cells.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Regulation of cell-cell adhesion GO:0022407
Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
2 P27782 (/IMP) P27782 (/IMP)
Regulation of cell-cell adhesion GO:0022407
Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
2 P27782 (/ISO) P27782 (/ISO)
Positive regulation of cell-cell adhesion GO:0022409
Any process that activates or increases the rate or extent of cell adhesion to another cell.
2 P27782 (/ISO) P27782 (/ISO)
Regulation of Wnt signaling pathway GO:0030111
Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
2 P27782 (/IGI) P27782 (/IGI)
Regulation of Wnt signaling pathway GO:0030111
Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Neutrophil differentiation GO:0030223
The process in which a myeloid precursor cell acquires the specialized features of a neutrophil.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Neutrophil differentiation GO:0030223
The process in which a myeloid precursor cell acquires the specialized features of a neutrophil.
2 P27782 (/ISO) P27782 (/ISO)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
2 P27782 (/ISO) P27782 (/ISO)
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
2 P27782 (/IGI) P27782 (/IGI)
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
2 P27782 (/ISO) P27782 (/ISO)
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2 P27782 (/IDA) P27782 (/IDA)
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Embryonic genitalia morphogenesis GO:0030538
The process, occurring in the embryo, by which the anatomical structures of the genitalia are generated and organized.
2 Q00417 (/IGI) Q924A0 (/IGI)
Positive regulation of granulocyte differentiation GO:0030854
Any process that activates or increases the frequency, rate or extent of granulocyte differentiation.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Positive regulation of granulocyte differentiation GO:0030854
Any process that activates or increases the frequency, rate or extent of granulocyte differentiation.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Positive regulation of granulocyte differentiation GO:0030854
Any process that activates or increases the frequency, rate or extent of granulocyte differentiation.
2 P27782 (/ISO) P27782 (/ISO)
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
2 P27782 (/IMP) P27782 (/IMP)
Midbrain development GO:0030901
The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
2 Q800Q5 (/IMP) Q9YHE8 (/IMP)
Negative regulation of interleukin-13 production GO:0032696
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-13 production.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of interleukin-13 production GO:0032696
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-13 production.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of interleukin-4 production GO:0032713
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-4 production.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of interleukin-4 production GO:0032713
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-4 production.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of interleukin-5 production GO:0032714
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of interleukin-5 production GO:0032714
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production.
2 P27782 (/ISO) P27782 (/ISO)
T cell receptor V(D)J recombination GO:0033153
The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
2 O93345 (/ISS) Q5R2J3 (/ISS)
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
2 Q924A0 (/IGI) Q9Z1J1 (/IGI)
Spiracle morphogenesis, open tracheal system GO:0035277
The process in which the anatomical structures of a spiracle are generated and organized. Spiracles are the openings in the insect open tracheal system; externally they connect to the epidermis and internally they connect to the tracheal trunk.
2 P91943 (/IMP) Q8IMA8 (/IMP)
B cell proliferation GO:0042100
The expansion of a B cell population by cell division. Follows B cell activation.
2 P27782 (/IMP) P27782 (/IMP)
B cell proliferation GO:0042100
The expansion of a B cell population by cell division. Follows B cell activation.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
2 P27782 (/IMP) P27782 (/IMP)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of DNA binding GO:0043392
Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of DNA binding GO:0043392
Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
2 P27782 (/ISO) P27782 (/ISO)
Tongue development GO:0043586
The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech.
2 P27782 (/IMP) P27782 (/IMP)
Tongue development GO:0043586
The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Skin development GO:0043588
The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
2 Q924A0 (/IGI) Q9Z1J1 (/IGI)
Positive regulation by host of viral transcription GO:0043923
Any process in which a host organism activates or increases the frequency, rate or extent of viral transcription, the synthesis of either RNA on a template of DNA or DNA on a template of RNA.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Positive regulation by host of viral transcription GO:0043923
Any process in which a host organism activates or increases the frequency, rate or extent of viral transcription, the synthesis of either RNA on a template of DNA or DNA on a template of RNA.
2 P27782 (/ISO) P27782 (/ISO)
Histone H3 acetylation GO:0043966
The modification of histone H3 by the addition of an acetyl group.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Histone H3 acetylation GO:0043966
The modification of histone H3 by the addition of an acetyl group.
2 P27782 (/ISO) P27782 (/ISO)
Histone H4 acetylation GO:0043967
The modification of histone H4 by the addition of an acetyl group.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Histone H4 acetylation GO:0043967
The modification of histone H4 by the addition of an acetyl group.
2 P27782 (/ISO) P27782 (/ISO)
T-helper 1 cell differentiation GO:0045063
The process in which a relatively unspecialized T cell acquires the specialized features of a T-helper 1 (Th1) cell. A Th1 cell is a CD4-positive, alpha-beta T cell that has the phenotype T-bet-positive and produces interferon-gamma.
2 P27782 (/IDA) P27782 (/IDA)
Negative regulation of striated muscle tissue development GO:0045843
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
2 P27782 (/IDA) P27782 (/IDA)
Negative regulation of striated muscle tissue development GO:0045843
Any process that stops, prevents, or reduces the frequency, rate or extent of striated muscle development.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 P27782 (/ISO) P27782 (/ISO)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2 P91943 (/IEP) Q8IMA8 (/IEP)
Alpha-beta T cell differentiation GO:0046632
The process in which a precursor cell type acquires the specialized features of an alpha-beta T cell. An alpha-beta T cell is a T cell that expresses an alpha-beta T cell receptor complex.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Paraxial mesoderm formation GO:0048341
The process that gives rise to the paraxial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
2 P27782 (/IGI) P27782 (/IGI)
Paraxial mesoderm formation GO:0048341
The process that gives rise to the paraxial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Cell development GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
2 P27782 (/IGI) P27782 (/IGI)
Cell development GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Embryonic digestive tract morphogenesis GO:0048557
The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed.
2 Q00417 (/IGI) Q924A0 (/IGI)
Embryonic hindgut morphogenesis GO:0048619
The process in which the anatomical structures of the hindgut are generated and organized, during the embryonic phase.
2 Q00417 (/IGI) Q924A0 (/IGI)
Generation of neurons GO:0048699
The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
2 Q800Q5 (/IGI) Q9YHE8 (/IGI)
Sensory perception of taste GO:0050909
The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process.
2 P27782 (/IMP) P27782 (/IMP)
Sensory perception of taste GO:0050909
The series of events required for an organism to receive a gustatory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Gustation involves the direct detection of chemical composition, usually through contact with chemoreceptor cells. This is a neurological process.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Roof of mouth development GO:0060021
The biological process whose specific outcome is the progression of the roof of the mouth from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The roof of the mouth is the partition that separates the nasal and oral cavities.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Anatomical structure regression GO:0060033
The developmental process in which an anatomical stucture is destroyed as a part of its normal progression.
2 P27782 (/IMP) P27782 (/IMP)
Anatomical structure regression GO:0060033
The developmental process in which an anatomical stucture is destroyed as a part of its normal progression.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
2 P27782 (/ISO) P27782 (/ISO)
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
2 P27782 (/ISO) P27782 (/ISO)
Apoptotic process involved in morphogenesis GO:0060561
Any apoptotic process that contributes to the shaping of an anatomical structure.
2 P27782 (/IMP) P27782 (/IMP)
Apoptotic process involved in morphogenesis GO:0060561
Any apoptotic process that contributes to the shaping of an anatomical structure.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Chorio-allantoic fusion GO:0060710
The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois.
2 P27782 (/IGI) P27782 (/IGI)
Endothelial cell fate specification GO:0060847
The process involved in the specification of identity of an endothelial cell. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
2 Q800Q5 (/IGI) Q9YHE8 (/IGI)
Endothelial cell fate specification GO:0060847
The process involved in the specification of identity of an endothelial cell. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
2 Q800Q5 (/IMP) Q9YHE8 (/IMP)
Trachea gland development GO:0061153
The progression of a trachea gland over time, from its formation to the mature structure. Trachea glands are found under the mucus of the trachea and secrete mucus, and agents that help protect the lung from injury and infection.
2 P27782 (/IMP) P27782 (/IMP)
Trachea gland development GO:0061153
The progression of a trachea gland over time, from its formation to the mature structure. Trachea glands are found under the mucus of the trachea and secrete mucus, and agents that help protect the lung from injury and infection.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
2 P27782 (/IMP) P27782 (/IMP)
Cellular response to cytokine stimulus GO:0071345
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Cellular response to cytokine stimulus GO:0071345
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
2 P27782 (/ISO) P27782 (/ISO)
Cellular response to interleukin-4 GO:0071353
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-4 stimulus.
2 P27782 (/ISO) P27782 (/ISO)
Positive regulation of cell proliferation in bone marrow GO:0071864
A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Positive regulation of cell proliferation in bone marrow GO:0071864
A process that activates or increases the frequency, rate or extent of cell proliferation in the bone marrow.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of apoptotic process in bone marrow cell GO:0071866
Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.
2 Q9UJU2 (/IMP) Q9UJU2 (/IMP)
Negative regulation of apoptotic process in bone marrow cell GO:0071866
Any process that stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.
2 P27782 (/ISO) P27782 (/ISO)
Odontoblast differentiation GO:0071895
The process in which a relatively unspecialized cell of neural crest origin acquires the specialized features of an odontoblast, a cell on the outer surface of the dental pulp whose biological function is the creation of dentin.
2 P27782 (/ISO) P27782 (/ISO)
Negative regulation of estrogen receptor binding GO:0071899
Any process that stops, prevents, or reduces the frequency, rate or extent of estrogen receptor binding, interacting selectively with an estrogen receptor.
2 Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Negative regulation of estrogen receptor binding GO:0071899
Any process that stops, prevents, or reduces the frequency, rate or extent of estrogen receptor binding, interacting selectively with an estrogen receptor.
2 P27782 (/ISO) P27782 (/ISO)
Regulation of stem cell proliferation GO:0072091
Any process that modulates the frequency, rate or extent of stem cell proliferation. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
2 P91943 (/IMP) Q8IMA8 (/IMP)
Positive regulation of cell cycle process GO:0090068
Any process that increases the rate, frequency or extent of a cellular process that is involved in the progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events.
2 P27782 (/ISO) P27782 (/ISO)
Apoptotic process involved in blood vessel morphogenesis GO:1902262
Any apoptotic process that is involved in blood vessel morphogenesis.
2 P27782 (/IMP) P27782 (/IMP)
Apoptotic process involved in blood vessel morphogenesis GO:1902262
Any apoptotic process that is involved in blood vessel morphogenesis.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 Q924A0 (/ISO)
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
1 Q924A0 (/ISO)
Cellular glucose homeostasis GO:0001678
A cellular homeostatic process involved in the maintenance of an internal steady state of glucose within a cell or between a cell and its external environment.
1 Q924A0 (/IMP)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
1 Q924A0 (/IMP)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
1 Q9QXN1 (/IEP)
Glycogen metabolic process GO:0005977
The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
1 Q924A0 (/IMP)
Glucose metabolic process GO:0006006
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.
1 Q924A0 (/IMP)
Chromatin organization GO:0006325
Any process that results in the specification, formation or maintenance of the physical structure of eukaryotic chromatin.
1 Q9HCS4 (/NAS)
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
1 Q9HCS4 (/NAS)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 Q924A0 (/IMP)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 Q924A0 (/ISO)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 P36402 (/TAS)
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
1 P36402 (/TAS)
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
1 Q924A0 (/ISO)
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
1 Q9QXN1 (/IEP)
Segment polarity determination GO:0007367
Division of the 14 parasegments of the embryo into anterior and posterior compartments; exemplified by the actions of the segment polarity gene products.
1 Q8IMA8 (/IGI)
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
1 Q8IMA8 (/ISS)
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
1 O93345 (/IMP)
Anterior/posterior axis specification, embryo GO:0008595
The specification of the anterior/posterior axis of the embryo by the products of genes expressed maternally and genes expressed in the zygote.
1 Q9Z1J1 (/IMP)
Cellular response to starvation GO:0009267
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
1 Q924A0 (/IMP)
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
1 Q924A0 (/IMP)
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
1 Q924A0 (/IMP)
Embryonic pattern specification GO:0009880
The process that results in the patterns of cell differentiation that will arise in an embryo.
1 Q8IMA8 (/ISS)
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
1 O93345 (/IMP)
Response to lithium ion GO:0010226
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus.
1 Q9QXN1 (/IEP)
Positive regulation of triglyceride biosynthetic process GO:0010867
Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.
1 Q924A0 (/IMP)
Positive regulation of heparan sulfate proteoglycan biosynthetic process GO:0010909
Any process that increases the rate, frequency or extent of heparan sulfate proteoglycan biosynthesis. Heparan sulfate proteoglycan biosynthetic processes are the chemical reactions and pathways resulting in the formation of the heparan sulfate proteoglycan, a glycosaminoglycan with repeat unit consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues.
1 Q924A0 (/ISO)
Oligodendrocyte development GO:0014003
The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
1 Q924A0 (/IMP)
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
1 Q9QXN1 (/IEP)
Wnt signaling pathway GO:0016055
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.
1 P91943 (/TAS)
Pituitary gland development GO:0021983
The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.
1 Q924A0 (/IMP)
Regulation of Wnt signaling pathway GO:0030111
Any process that modulates the frequency, rate or extent of the activity of the Wnt signal transduction pathway.
1 Q9HCS4 (/NAS)
Negative regulation of Wnt signaling pathway GO:0030178
Any process that stops, prevents, or reduces the frequency, rate or extent of the Wnt signaling pathway.
1 Q9YHE8 (/IMP)
Bone mineralization GO:0030282
The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
1 Q924A0 (/IGI)
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
1 Q924A0 (/IMP)
Forebrain development GO:0030900
The process whose specific outcome is the progression of the forebrain over time, from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes especially the cerebral hemispheres, the thalamus, and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing, visceral functions, and voluntary motor functions).
1 Q9YHE8 (/IGI)
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
1 Q800Q5 (/IMP)
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
1 Q9QXN1 (/IEP)
Regulation of myelination GO:0031641
Any process that modulates the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
1 Q924A0 (/IMP)
Positive regulation of insulin secretion GO:0032024
Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.
1 Q924A0 (/ISO)
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
1 Q924A0 (/ISO)
Secretory granule localization GO:0032252
Any process in which a secretory granule is transported to, and/or maintained in, a specific location within the cell.
1 Q924A0 (/IMP)
Regulation of hormone metabolic process GO:0032350
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone.
1 Q924A0 (/ISO)
Somatic stem cell population maintenance GO:0035019
Any process by which an organism retains a population of somatic stem cells, undifferentiated cells in the embryo or adult which can undergo unlimited division and give rise to cell types of the body other than those of the germ-line.
1 Q924A0 (/IMP)
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
1 O93345 (/IMP)
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
1 O93345 (/NAS)
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
1 Q924A0 (/IMP)
Spiracle morphogenesis, open tracheal system GO:0035277
The process in which the anatomical structures of a spiracle are generated and organized. Spiracles are the openings in the insect open tracheal system; externally they connect to the epidermis and internally they connect to the tracheal trunk.
1 Q8IMA8 (/ISS)
Brain segmentation GO:0035284
Division of the brain into a series of semi-repetitive parts or segments.
1 Q800Q5 (/IMP)
Chitin-based larval cuticle pattern formation GO:0035293
The process that gives rise to the patterns of cell differentiation in the chitin-based larval cuticle. An example of this is found in Drosophila melanogaster.
1 Q8IMA8 (/IGI)
Regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter GO:0035947
Any process that modulates the frequency, rate or extent of gluconeogenesis, by regulation of transcription from an RNA polymerase II promoter.
1 Q924A0 (/IMP)
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
1 Q924A0 (/IMP)
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
1 Q00417 (/IDA)
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
1 Q5R2J3 (/ISS)
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
1 Q924A0 (/IMP)
Glucose homeostasis GO:0042593
Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
1 Q924A0 (/ISO)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
1 Q924A0 (/IMP)
Negative regulation of DNA-binding transcription factor activity GO:0043433
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
1 Q924A0 (/ISO)
Maintenance of DNA repeat elements GO:0043570
Any process involved in sustaining the fidelity and copy number of DNA repeat elements.
1 Q924A0 (/ISO)
Skin development GO:0043588
The process whose specific outcome is the progression of the skin over time, from its formation to the mature structure. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
1 Q9QXN1 (/IEP)
Canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition GO:0044334
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of epithelial cell to mesenchymal cell transition.
1 Q924A0 (/ISO)
Canonical Wnt signaling pathway involved in negative regulation of apoptotic process GO:0044336
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the negative regulation of apoptotic process.
1 Q00417 (/IDA)
Fat cell differentiation GO:0045444
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.
1 Q924A0 (/ISO)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
1 Q924A0 (/IMP)
Negative regulation of neuron differentiation GO:0045665
Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
1 O93345 (/IMP)
Positive regulation of gluconeogenesis GO:0045722
Any process that activates or increases the frequency, rate or extent of gluconeogenesis.
1 Q924A0 (/IMP)
Negative regulation of organ growth GO:0046621
Any process that stops, prevents, or reduces the frequency, rate or extent of growth of an organ of an organism.
1 Q924A0 (/IMP)
Positive regulation of protein export from nucleus GO:0046827
Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm.
1 Q924A0 (/ISO)
Positive regulation of lipid biosynthetic process GO:0046889
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids.
1 Q924A0 (/IMP)
Eye pigmentation GO:0048069
Establishment of a pattern of pigment in the eye of an organism.
1 O93345 (/IMP)
Axial mesoderm morphogenesis GO:0048319
The process in which the anatomical structures of the axial mesoderm are generated and organized.
1 Q9Z1J1 (/IMP)
Embryonic camera-type eye morphogenesis GO:0048596
The process in which the anatomical structures of the eye are generated and organized during embryonic development.
1 Q9YHE8 (/IGI)
Myoblast fate commitment GO:0048625
The process in which the developmental fate of a cell becomes restricted such that it will develop into a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
1 Q924A0 (/IMP)
Myoblast fate commitment GO:0048625
The process in which the developmental fate of a cell becomes restricted such that it will develop into a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
1 Q924A0 (/ISO)
Regulation of skeletal muscle tissue development GO:0048641
Any process that modulates the frequency, rate or extent of skeletal muscle tissue development.
1 Q924A0 (/IMP)
Regulation of smooth muscle cell proliferation GO:0048660
Any process that modulates the frequency, rate or extent of smooth muscle cell proliferation.
1 Q924A0 (/ISO)
Regulation of oligodendrocyte differentiation GO:0048713
Any process that modulates the frequency, rate or extent of oligodendrocyte differentiation.
1 Q924A0 (/IMP)
Stem cell differentiation GO:0048863
The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
1 Q9Z1J1 (/IMP)
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
1 Q924A0 (/ISO)
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
1 Q924A0 (/ISO)
Canonical Wnt signaling pathway GO:0060070
The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
1 O93345 (/NAS)
Head morphogenesis GO:0060323
The process in which the anatomical structures of the head are generated and organized. The head is the anterior-most division of the body.
1 Q9YHE8 (/IMP)
Iris morphogenesis GO:0061072
The process in which the iris is generated and organized. The iris is an anatomical structure in the eye whose opening forms the pupil. The iris is responsible for controlling the diameter and size of the pupil and the amount of light reaching the retina.
1 O93345 (/IMP)
Ciliary body morphogenesis GO:0061073
The process in which the ciliary body generated and organized. The ciliary body is the circumferential tissue inside the eye composed of the ciliary muscle and ciliary processes.
1 O93345 (/IMP)
Regulation of insulin secretion involved in cellular response to glucose stimulus GO:0061178
Any process that modulates the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
1 Q924A0 (/IMP)
Odontoblast differentiation GO:0071895
The process in which a relatively unspecialized cell of neural crest origin acquires the specialized features of an odontoblast, a cell on the outer surface of the dental pulp whose biological function is the creation of dentin.
1 Q9QXN1 (/IMP)
Negative regulation of canonical Wnt signaling pathway GO:0090090
Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
1 Q924A0 (/ISO)
Cell elongation involved in imaginal disc-derived wing morphogenesis GO:0090254
The process in which a cell elongates and contributes to imaginal disc-derived wing morphogenesis.
1 Q8IMA8 (/IMP)
Insulin metabolic process GO:1901142
The chemical reactions and pathways involving insulin.
1 Q924A0 (/IMP)
Regulation of stem cell population maintenance GO:2000036
Any process that modulates the frequency, rate or extent of stem cell population maintenance.
1 Q9Z1J1 (/IMP)
Negative regulation of type B pancreatic cell apoptotic process GO:2000675
Any process that stops, prevents or reduces the frequency, rate or extent of type B pancreatic cell apoptotic process.
1 D4A8X6 (/IMP)
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
1 D4A8X6 (/IMP)

There are 30 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
31 A0A2R8Q786 (/IDA) A0A2R8QTB4 (/IDA) A0A2R8RU78 (/IDA) B3DKP7 (/IDA) E9QC17 (/IDA) E9QFQ3 (/IDA) F1Q7T6 (/IDA) F1QC44 (/IDA) F1RC81 (/IDA) O93345 (/IDA)
(21 more)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
9 P36402 (/TAS) P91943 (/TAS) Q9HCS4 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9NQB0 (/TAS) Q9QXN1 (/TAS) Q9UJU2 (/TAS) Q9UJU2 (/TAS)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
7 B7WNT5 (/IDA) B7WNT5 (/IDA) P36402 (/IDA) Q9HCS4 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
6 P27782 (/IPI) P27782 (/IPI) P70062 (/IPI) P70062 (/IPI) P91943 (/IPI) Q8IMA8 (/IPI)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
5 O93345 (/IDA) P27782 (/IDA) P27782 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Protein-DNA complex GO:0032993
A macromolecular complex containing both protein and DNA molecules.
5 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
4 P70062 (/IC) P70062 (/IC) Q9UJU2 (/IC) Q9UJU2 (/IC)
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
3 Q924A0 (/IDA) Q9UJU2 (/IDA) Q9UJU2 (/IDA)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
3 O93345 (/ISS) Q5R2J3 (/ISS) Q6GL68 (/ISS)
Nuclear body GO:0016604
Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
3 B7WNT5 (/IDA) B7WNT5 (/IDA) P36402 (/IDA)
Protein-DNA complex GO:0032993
A macromolecular complex containing both protein and DNA molecules.
3 P27782 (/ISO) P27782 (/ISO) Q924A0 (/ISO)
Beta-catenin-TCF7L2 complex GO:0070369
A protein complex that contains beta-catenin and TCF7L2 (TCF4), binds to the TCF DNA motif within a promoter element, and is involved in the regulation of WNT target gene transcription.
3 Q9NQB0 (/IDA) Q9NQB0 (/IDA) Q9NQB0 (/IDA)
Beta-catenin-TCF complex GO:1990907
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
3 Q8IMA8 (/IPI) Q9UJU2 (/IPI) Q9UJU2 (/IPI)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
2 Q924A0 (/ISO) Q9Z1J1 (/ISO)
Transcription factor complex GO:0005667
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.
2 P27782 (/ISO) P27782 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 P27782 (/ISO) P27782 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 O93345 (/ISS) Q5R2J3 (/ISS)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
2 Q924A0 (/IDA) Q9HCS4 (/IDA)
Beta-catenin-TCF complex GO:1990907
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
2 P27782 (/IC) P27782 (/IC)
Beta-catenin-TCF complex GO:1990907
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
2 P27782 (/ISO) P27782 (/ISO)
Nuclear chromatin GO:0000790
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus.
1 Q924A0 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 Q9HCS4 (/NAS)
Nuclear euchromatin GO:0005719
The dispersed less dense form of chromatin in the interphase nucleus. It exists in at least two forms, a some being in the form of transcriptionally active chromatin which is the least condensed, while the rest is inactive euchromatin which is more condensed than active chromatin but less condensed than heterochromatin.
1 Q00417 (/IDA)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
1 Q9Z1J1 (/ISO)
Beta-catenin-TCF7L2 complex GO:0070369
A protein complex that contains beta-catenin and TCF7L2 (TCF4), binds to the TCF DNA motif within a promoter element, and is involved in the regulation of WNT target gene transcription.
1 Q924A0 (/ISO)
Catenin-TCF7L2 complex GO:0071664
A protein complex that contains a catenin and TCF7L2 (TCF4), binds to the TCF DNA motif within a promoter element, and is involved in the regulation of WNT target gene transcription.
1 Q924A0 (/IDA)
Beta-catenin-TCF complex GO:1990907
A protein complex that contains beta-catenin and a member of the T-cell factor (TCF)/lymphoid enhancer binding factor (LEF) family of transcription factors.
1 Q8IMA8 (/IMP)
CATH-Gene3D is a Global Biodata Core Resource Learn more...